Factors associated with neoadjuvant therapy insensitivity and its prognostic impact in HER2-positive breast cancer
摘要: Objective: A subset of patients with human epidermal growth factor receptor 2 positive(HER2+) breast cancer shows insensitivity to neoadjuvant therapy(NAT), often evidenced by imaging result... ...
(共11页)
开通会员,享受整站包年服务